Topics

Gene therapy prevents disorders with alcohol exposure in ALDH2 deficiency

19:00 EST 11 Feb 2020 | AAAS

(Mary Ann Liebert, Inc./Genetic Engineering News) A new study has shown that gene therapy to treat one of the most common hereditary disorders, aldehyde dehydrogenase type 2 (ALDH2) deficiency, may prevent increased risk for esophageal cancer and osteoporosis associated with chronic alcohol exposure.

Original Article: Gene therapy prevents disorders with alcohol exposure in ALDH2 deficiency

NEXT ARTICLE

More From BioPortfolio on "Gene therapy prevents disorders with alcohol exposure in ALDH2 deficiency"

Quick Search

Relevant Topics

Genetic Engineering
Genetic engineering is the process of manually adding new DNA to an organism. The goal is to add one or more new traits that are not already found in that organism. Examples of genetically engineered (transgenic) organisms currently on the market include...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...